FDA Inspection 887354 — Aesica Pharmaceuticals GmbH

Aesica Pharmaceuticals GmbH — FEI 3002948883

The FDA completed an inspection of Aesica Pharmaceuticals GmbH on Jun 20, 2014 in Zwickau. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 20, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Zwickau (Germany)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
202721 CFR 211.192Investigations of discrepancies, failures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.